What's breaking now, across thousands of outlets.
Amgen reported a key clinical win for its T cell engager platform, finding that Imdelltra combined with a checkpoint inhibitor helped patients with advanced lung cancer live longer. The California pharma company
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
"In many cases, these devices are better suited to tracking trends over time, rather than as precise laboratory measurements."
New York Mayor Zohran Mamdani announced on Tuesday the release of tens of thousands of documents showing the city did not disclose all it knew about air toxicity after September 11. The release comes ahead of the 25th anniversary of the attacks in 2001 that killed 2,977 people, in the US, mostly in the collapse of the Twin Towers in New…
An expert shares guidance to help owners better understand changes in their pets' behavior and learn how to care for animals living with dementia.
The digitization of healthcare has generated vast, longitudinal, and multimodal patient records over a lifetime, yet fully exploiting these data to represent and predict patient state trajectories…
Rather than requiring genetic modification of the viral glycoprotein, G-Link uses a modular protein adaptor to blind native VSV-G tropism and redirect delivery after vector production.
A team from the Research Institute of the McGill University Health Center (The Institute) have created a three-dimensional, beating heart-on-a-chip, or "mini-heart," using blood cells from a patient with dilated cardiomyopathy (DCM), a leading cause of heart transplantation.
